Article

Bausch & Lomb plans to double size of R&D center

Bausch & Lomb announced it will nearly double the size of its main research and development (R&D) center in Rochester, NY. The new two-story, 75,000-square-foot glass-and-brick wing will house laboratories and offices. It also will allow room for a future 25,000-square-foot addition.

Bausch & Lomb announced it will nearly double the size of its main research and development (R&D) center in Rochester, NY. The new two-story, 75,000-square-foot glass-and-brick wing will house laboratories and offices. It also will allow room for a future 25,000-square-foot addition.

The $35 million project includes $25 million for new construction and $10 million for renovations, equipment, and machinery, the company said in a prepared statement. The company is projected to add as many as 200 research jobs over the next 2 years.

The expansion "demonstrates our commitment to continue to develop innovative products to help people see, and will facilitate our plans to increase our presence in the nearly $20 billion global eye-health market," said Praveen Tyle, PhD, senior vice president and chief scientific officer of Bausch & Lomb.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.